Common knowledge about chemotherapy for lung cancer

Chemotherapy is also one of the important methods for lung cancer treatment. It has a good therapeutic effect on some poorly differentiated lung cancers, especially small cell lung cancer. Because chemotherapy can act throughout the body, it can be used alone in the clinical treatment of patients with advanced lung cancer to effectively relieve symptoms. It can also be combined with surgical treatment, radiotherapy, etc. to prevent cancer metastasis and recurrence and improve the cure rate.

Commonly used chemotherapy drugs for the treatment of lung cancer include cyclophosphamide, fluorouracil, mitomycin, doxorubicin, epirubicin, procarbazine, vinblastine, methotrexate, lomustine, cisplatin, carboplatin, paclitaxel, gemcitabine, etc. In clinical application, the drugs are rationally selected according to the pathological tissue classification of lung cancer and the patient's general condition, and the administration method is selected according to whether it is simple chemotherapy or adjuvant chemotherapy, the length of the treatment course is determined, and which drugs are used in combination, intermittent administration, etc., to improve the effect of chemotherapy.

It should be noted that the efficacy of chemotherapy for lung cancer is still very low, the symptom relief period is short, and there are many side effects. In clinical application, it is necessary to master the performance and dosage of the drug and closely observe the side effects. Once bone marrow hematopoietic function suppression, immune function suppression, secondary infection, severe gastrointestinal reactions, etc. occur, the drug dosage should be adjusted in time or the administration should be suspended, and corresponding treatment should be given.